SynBiotic SE (DUSE:SBX)
Germany · Delayed Price · Currency is EUR 1.148
-0.112 (-8.89%)
At close: Jul 3, 2026
SynBiotic SE Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 14.31 | 3.86 | 8.17 | 8.65 | 5.45 |
Other Revenue | 0.55 | 0.16 | - | 0.42 | 0.03 |
| 14.86 | 4.02 | 8.17 | 9.06 | 5.47 | |
Revenue Growth | 269.31% | -50.73% | -9.91% | 65.63% | - |
Cost of Revenue | 9.44 | 2.35 | 4.59 | 3.86 | 1.73 |
Gross Profit | 5.41 | 1.67 | 3.57 | 5.2 | 3.74 |
Selling, General & Admin | 3.72 | 2.51 | 6.02 | 2.42 | 0.73 |
Other Operating Expenses | 3.99 | 6.4 | 4.92 | 7.56 | 3.61 |
Operating Expenses | 8.68 | 10.01 | 12.9 | 10.78 | 4.57 |
Operating Income | -3.27 | -8.34 | -9.32 | -5.58 | -0.83 |
Interest Expense | -0.43 | -0.2 | -0.19 | -0.05 | -0.02 |
Interest & Investment Income | 0.14 | 0.08 | 0.15 | 0.13 | 0.02 |
Earnings From Equity Investments | - | -0.01 | -0.23 | -1.95 | -0.02 |
Currency Exchange Gain (Loss) | - | - | 0 | - | - |
Other Non Operating Income (Expenses) | 0.03 | 0.05 | 0.31 | - | - |
EBT Excluding Unusual Items | -3.54 | -8.42 | -9.27 | -7.44 | -0.86 |
Impairment of Goodwill | -7.34 | -3.46 | -16.91 | -5.92 | - |
Pretax Income | -10.88 | -11.87 | -26.19 | -13.36 | -0.86 |
Income Tax Expense | 0.01 | -0.13 | -0.19 | -0.29 | 0.02 |
Earnings From Continuing Operations | -10.89 | -11.74 | -26 | -13.07 | -0.88 |
Minority Interest in Earnings | 1.17 | 1.11 | 1.64 | 0.35 | - |
Net Income | -9.72 | -10.63 | -24.36 | -12.72 | -0.88 |
Net Income to Common | -9.72 | -10.63 | -24.36 | -12.72 | -0.88 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 6 | 5 | 4 | 3 | 2 |
Shares Outstanding (Diluted) | 6 | 5 | 4 | 3 | 2 |
Shares Change | 23.07% | 16.35% | 33.09% | 96.39% | 524.66% |
EPS (Basic) | -1.66 | -2.24 | -5.97 | -4.15 | -0.56 |
EPS (Diluted) | -1.66 | -2.24 | -5.97 | -4.15 | -0.56 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -0.65 | -2.94 | -7.27 | -5.51 | -1.28 |
Free Cash Flow Per Share | -0.11 | -0.62 | -1.78 | -1.80 | -0.82 |
Gross Margin | 36.44% | 41.47% | 43.75% | 57.38% | 68.33% |
Operating Margin | -22.02% | -207.39% | -114.19% | -61.55% | -15.24% |
Profit Margin | -65.39% | -264.24% | -298.35% | -140.39% | -16.09% |
Free Cash Flow Margin | -4.41% | -73.16% | -89.08% | -60.79% | -23.41% |
EBITDA | -2.51 | -7.48 | -7.97 | -4.83 | -0.71 |
EBITDA Margin | -16.91% | -185.81% | -97.61% | -53.33% | -13.05% |
D&A For EBITDA | 0.76 | 0.87 | 1.35 | 0.74 | 0.12 |
EBIT | -3.27 | -8.34 | -9.32 | -5.58 | -0.83 |
EBIT Margin | -22.02% | -207.39% | -114.19% | -61.55% | -15.24% |
Advertising Expenses | 0.44 | 0.37 | 1.28 | 1.58 | 0.82 |